Organigram to Acquire Aurora and Establish a Global Cannabis Leader

What happened

Organigram Global agreed to acquire all Aurora Cannabis shares for C$7.80 each, valuing Aurora at about C$561 million. The price is a 93% premium to Aurora's closing price on August 10, 2026, before Curaleaf announced its hostile bid for Aurora.

Confirmed

Global impact / market context

Aurora shareholders are offered a large premium over the price before Curaleaf's hostile bid, giving them a choice between accepting Organigram's offer or backing Curaleaf's bid. For Organigram, buying Aurora adds scale in Canada, Europe and Australia but requires paying a high price.

Analyst inference

The deal is a competing bid against Curaleaf's hostile takeover attempt, so Aurora shareholders now face two options. Organigram's offer is 21% above Curaleaf's latest bid value. A takeover battle can raise the final price paid, shifting value between Aurora shareholders and the winning buyer's shareholders.

Analyst inference

What to watch

1. Aurora's board unanimously rejected Curaleaf's hostile bid, so watch whether directors recommend Organigram's agreed offer to shareholders and how they compare the two proposals. Confirmed
2. Watch whether Curaleaf raises its hostile bid in response to Organigram's C$7.80 per share offer, since a higher bid would change the value Aurora shareholders can receive. Proposed
3. Watch whether the combined company's added scale in Canada, Europe and Australia leads to cost savings or higher capital spending, which would affect future profit and cash available. Analyst inference

Evidence

• Original source link unavailable